Inventor · Ashland, MA, US

Qun Zhou

28Patents
6h-index
43Co-inventors
69Inventor score

Filing activity: Jul 2, 1992 → Feb 14, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7700321B2 Antibody-based therapeutics with enhanced ADCC activity Chemistry; Metallurgy 15 Active
US5389543A Cloned genes encoding the D.sub.1 dopamine receptor Chemistry; Metallurgy 15 Expired
US9580511B2 Site-specific antibody-drug conjugation through glycoengineering Chemistry; Metallurgy 13 Active
US8835614B2 Oligosaccharide-protein conjugates Human Necessities 8 Active
US5441883A A3 adenosine receptor, DNA, and uses Human Necessities 8 Expired
US10214589B2 Site-specific antibody-drug conjugation through glycoengineering Chemistry; Metallurgy 7 Active
US7052674B2 Prokineticin polypeptides, related compositions and methods Human Necessities 6 Expired
US10995148B2 Site-specific glycoengineering of targeting moieties Chemistry; Metallurgy 6 Active
US10064952B2 Glycoengineered antibody drug conjugates Chemistry; Metallurgy 6 Active
US9493498B2 Oligosaccharide-protein conjugates Human Necessities 6 Active
US10464962B2 Oligosaccharide-protein conjugates Human Necessities 5 Active
US11279725B2 Oligosaccharide-protein conjugates Human Necessities 5 Active
US8071336B2 Antibody-based therapeutics with enhanced ADCC activity Chemistry; Metallurgy 5 Active
US11130816B2 Site-specific antibody-drug conjugation through glycoengineering Chemistry; Metallurgy 4 Active
US11160874B2 Glycoengineered antibody drug conjugates Chemistry; Metallurgy 4 Active
US12110338B2 Site-specific antibody-drug conjugation through glycoengineering Chemistry; Metallurgy 1 Active
US7259240B2 Primate prokineticin receptor polypeptides Chemistry; Metallurgy 1 Expired
US7115560B2 Methods for modulating gastric secretion using prokineticin receptor antagonists Human Necessities 1 Expired
US9494666B2 NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesium Physics 1 Active
US7598048B2 Screening methods for identifying agents that modulate output of a circadian pacemaker Physics 0 Expired
US8722896B2 Prokineticin receptor antagonists and uses thereof Chemistry; Metallurgy 0 Active
US11879004B2 Modified binding polypeptides for optimized drug conjugation Chemistry; Metallurgy 0 Active
US8101158B1 Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity Human Necessities 0 Active
US12252504B2 Oligosaccharide-protein conjugates Human Necessities 0 Active
US5547845A Aqueous solution containing D.sub.1 dopamine receptor Chemistry; Metallurgy 0 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.